KM Pharma Calls EGM for Article Amendments and Executive Compensation Rules
-
Board resolved to call an EGM on June 23, 2026; record date May 22, 2026
-
Agenda: amend articles (reflect commercial law changes, align compensation rules), approve new executive compensation regulations, amend executive severance pay regulations
KOSDAQ Filing Information
-
-
Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)
-
Company: KMPHARMACEUTICAL (225430)
-
Submission: KMPHARMACEUTICAL Co.,Ltd.
-
Under KRX KOSDAQ Market Division
-
-
Shares: 27,887,050
-
Price: 517 KRW
-
Market Cap: 14.4 B KRW